XNAS · Healthcare · Medical Devices
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | Q1 2026 | -0.54 | -0.43 | +20.37% | $0 | ✅ Beat | +0.00% | -3.15% | — |
| 2026-03-02 | Q4 2025 | -0.54 | -0.14 | +74.07% | $0 | ✅ Beat | -3.36% | +2.52% | -2.52% |
| 2025-11-14 |
| Q3 2025 |
| -1.23 |
| -0.37 |
| +69.92% |
| $0 |
| ✅ Beat |
| — |
| — |
| — |
| 2025-08-14 | Q2 2025 | -0.58 | -1.33 | -129.31% | $0 | ❌ Miss | +2.13% | -7.66% | -9.36% |
| 2025-02-28 | Q4 2024 | -0.65 | -0.48 | +26.15% | $0 | ✅ Beat | -7.56% | -5.48% | -9.98% |
| 2024-11-14 | Q3 2024 | -0.60 | -2.37 | -295.00% | $0 | ❌ Miss | -7.75% | -4.65% | -12.40% |
| 2024-08-09 | Q2 2024 | -1.39 | -0.67 | +51.80% | $0 | ✅ Beat | -4.14% | -11.24% | -32.54% |
| 2024-05-14 | Q1 2024 | -7.60 | -1.31 | +82.76% | $0 | ✅ Beat | -1.30% | -36.52% | -32.17% |
Showing last 8 quarters.